latest news releases from the newsroom
NetManage Announces China Expansion
SHANGHAI, China and CUPERTINO, Calif., Oct. 22, 2007 (PRIME NEWSWIRE) -- NetManage, Inc. (Nasdaq:NETM), a software company that provides the fastest way to transform legacy applications into new Web-based business solutions, today announced it has opened an office in Shanghai, China, offering a suite of integration technology tools and professional services to its 2,000 global customers in the region.
Kinship Center-Canyon Acres
I Padrini d'Antonello's 'An Evening Under the Stars' Nets More Than $200,000
ANAHEIM HILLS, Calif., Oct. 22, 2007 (PRIME NEWSWIRE) -- Canyon Acres Children and Family services, a charity organization committed to providing homes, care, treatment and supportive services for abused, neglected and emotionally troubled children and their families, today announced the success of 'An Evening Under the Stars,' an event hosted by I Padrini d'Antonello on October 7, 2007. The event took place at Antonello Ristorante and netted more than $200,000.
Penwest Pharmaceuticals Co.
Penwest Third Quarter 2007 Financial Results Conference Call
DANBURY, Conn., Oct. 22, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Friday, November 2, 2007, at 11:00 a.m. EDT to review its financial results for the third quarter of 2007, which will be released earlier that day. Operational developments and financial outlook will also be discussed on the call.
SenoRx Launches Products in Ten Countries
ALISO VIEJO, Calif., Oct. 22, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has launched EnCor(r), its flagship vacuum-assisted breast biopsy product, and its line of breast biopsy tissue markers in ten countries outside the United States. SenoRx is partnering with local distributors who have breast imaging and/or interventional radiology franchises in Austria, Belgium, England, Hong Kong, Ireland, Luxembourg, The Netherlands, Singapore, Switzerland and Taiwan. EnCor and SenoRx breast tissue markers have previously received the necessary regulatory clearances in the European Economic Community and in these and several other countries in Asia.